Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

1 Apr 2019 07:00

RNS Number : 5689U
Johnson Matthey PLC
01 April 2019
 

Dr Xiaozhi Liu to join Johnson Matthey as a Non-Executive Director

The board of Johnson Matthey Plc is pleased to announce the appointment of Dr Xiaozhi Liu as a Non-Executive Director of the company. She joins the board with effect from 2nd April 2019.

 

Xiaozhi has worked extensively in the automotive sector, particularly in China, as well as in Europe and the US. Her knowledge and perspective on technology driven businesses in China and globally will complement and enhance that of our other board members, particularly as the automotive powertrain evolves.

 

Currently Xiaozhi is the Chief Executive of ASL Automobile Science & Technology (Shanghai) Co., Ltd., a consulting and business development company which she founded in June 2009 focusing on automotive innovation and technology commercialisation, particularly for the Chinese market.

 

Prior to founding ASL, between January 2007 and December 2009, Xiaozhi held positions as President, Chief Executive and Chairman of Neotek Corporation, a manufacturer of brake components and other automobile parts. Before that she held various positions within the General Motors Group, including as Director of Electronics, Controls and Software in the US and Managing Director of General Motors Taiwan.

 

As well as bringing deep, relevant executive experience, Xiaozhi also holds non-executive director positions at Autoliv, a global automotive safety supplier from Sweden, at Fuyao Glass Industry Group Co., Ltd, a global automotive glass manufacturing company from China, and at Anheuser-Busch InBev SA/NV, a multinational drink and brewing holdings company based in Leuven, Belgium.

 

Odile Desforges will stand down from her role as a non-executive director at the end of the company's Annual General Meeting in July 2019, after six years as a member of our board.

 

Speaking on these board changes Patrick Thomas, Chairman of Johnson Matthey said:

 

"On behalf of the board I would like to thank Odile for her valuable contributions, including her automotive industry insights, during her time as a non-executive director and we all wish her well for the future.

 

I am very pleased to welcome Xiaozhi to our board and I know that we will benefit from the perspective and experience that she brings. This is particularly relevant and valuable to Johnson Matthey as our markets, customers and organisation continue to evolve and grow. We are looking forward to working with her and it is great to have Xiaozhi join the team."

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years):

 

Xiaozhi was appointed as a director of Autoliv, Inc in November 2011, a company listed on the New York Stock Exchange.

 

In October 2013, Xiaozhi was appointed as a director of Fuyao Glass Industry Group Co., Ltd., a company listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange.

 

In March 2019, Xiaozhi was appointed as a director of Anheuser-Busch InBev SA/NV, a company listed on Euronext Brussels, subject to shareholder approval.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

Analysts and investors:

Martin Dunwoodie

+44 (0)20 7269 8241

Louise Curran

+44 (0)20 7269 8235

Jane Crosby

+44 (0)20 7269 8242

Media:

Sally Jones

+44 (0)20 7269 8407

www.matthey.com

1st April 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMGZFNLMGLZM
Date   Source Headline
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM
17th Jul 20257:00 amRNSAppointment of Andrew Cosslett as Chair
9th Jul 20254:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.